Comparative pharmacokinetics and preliminary efficacy of two topical vaginal formulations of estriol (0.005% estriol vaginal gel, and 0.002% estriol vaginal gel) vs. the marketed reference product (Ovestinon, estriol vaginal cream 0.1%) in post-menopausal healthy volunteers. Abstracts of the 13th World Congress on the Menopause - Nieto, C; Delgado, J L; Estévez, J (Climacteric, 2011)
et al.